JP5748751B2 - 糖尿病前症及び２型糖尿病における血清アミロイドの表現型比率 - Google Patents

糖尿病前症及び２型糖尿病における血清アミロイドの表現型比率 Download PDF

Info

Publication number
JP5748751B2
JP5748751B2 JP2012519637A JP2012519637A JP5748751B2 JP 5748751 B2 JP5748751 B2 JP 5748751B2 JP 2012519637 A JP2012519637 A JP 2012519637A JP 2012519637 A JP2012519637 A JP 2012519637A JP 5748751 B2 JP5748751 B2 JP 5748751B2
Authority
JP
Japan
Prior art keywords
saa
diabetes
measured amount
ratio
phenotype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012519637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533065A (ja
JP2012533065A5 (enExample
Inventor
エー． キールナン，アーバン
エー． キールナン，アーバン
ネデルコフ，ドブリン
Original Assignee
イントリンジック バイオプローブズ，インコーポレイテッド
イントリンジック バイオプローブズ，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イントリンジック バイオプローブズ，インコーポレイテッド, イントリンジック バイオプローブズ，インコーポレイテッド filed Critical イントリンジック バイオプローブズ，インコーポレイテッド
Publication of JP2012533065A publication Critical patent/JP2012533065A/ja
Publication of JP2012533065A5 publication Critical patent/JP2012533065A5/ja
Application granted granted Critical
Publication of JP5748751B2 publication Critical patent/JP5748751B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2012519637A 2009-07-07 2010-07-02 糖尿病前症及び２型糖尿病における血清アミロイドの表現型比率 Active JP5748751B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22349809P 2009-07-07 2009-07-07
US61/223,498 2009-07-07
PCT/US2010/040997 WO2011005717A1 (en) 2009-07-07 2010-07-02 Phenotypic ratio of serum amyloid in pre- and type 2 diabetes

Publications (3)

Publication Number Publication Date
JP2012533065A JP2012533065A (ja) 2012-12-20
JP2012533065A5 JP2012533065A5 (enExample) 2013-05-30
JP5748751B2 true JP5748751B2 (ja) 2015-07-15

Family

ID=43427764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519637A Active JP5748751B2 (ja) 2009-07-07 2010-07-02 糖尿病前症及び２型糖尿病における血清アミロイドの表現型比率

Country Status (5)

Country Link
US (1) US20110008799A1 (enExample)
EP (1) EP2451465B1 (enExample)
JP (1) JP5748751B2 (enExample)
CN (1) CN102481320A (enExample)
WO (1) WO2011005717A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160112810A (ko) * 2015-03-20 2016-09-28 삼성전자주식회사 이미지 처리 방법 및 그 전자 장치
CN113080114A (zh) * 2021-04-12 2021-07-09 浙江大学 一种提高鱼类子代成活率的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
JP2005503537A (ja) * 2001-01-17 2005-02-03 エー． タブス，ケモンズ 生体分子分析用ハイ・スループット統合システム
AUPR589801A0 (en) * 2001-06-22 2001-07-19 Autogen Research Pty Ltd Modulation of physiological processes and agents useful for same
US20070087448A1 (en) * 2004-02-16 2007-04-19 Nelsestuen Gary L Biological profiles and methods of use
US8119358B2 (en) * 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
JP2008228646A (ja) * 2007-03-20 2008-10-02 Hokkaido Univ ２型糖尿病診断剤
CA2692970A1 (en) * 2007-07-03 2009-01-08 Northeastern University Biomarkers for diabetes, obesity, and/or hypertension

Also Published As

Publication number Publication date
EP2451465A4 (en) 2013-01-23
WO2011005717A1 (en) 2011-01-13
EP2451465A1 (en) 2012-05-16
CN102481320A (zh) 2012-05-30
JP2012533065A (ja) 2012-12-20
EP2451465B1 (en) 2017-08-23
US20110008799A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
Kiernan et al. Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay
JP2011515680A (ja) 糖尿病のためのバイオマーカーおよびアッセイ
US20150090010A1 (en) Method for diagnosing heart failure
US20140148349A1 (en) Metabolite Biomarkers for the Detection of Esophageal Cancer Using NMR
Joshi et al. Recent progress in mass spectrometry-based urinary proteomics
CN112903885B (zh) 一种筛查糖尿病的联合型代谢标志物的应用及其试剂盒
CN114026427A (zh) 诊断肾病的标志物以及诊断方法
Liang et al. Metabolomics of alcoholic liver disease: a clinical discovery study
JP5876826B2 (ja) 糖尿病前症及び２型糖尿病におけるアポリポタンパク質ｃｉｉｉ
CN115327129A (zh) 一种血浆分子标志物犬尿氨酸在早期心力衰竭检测中的应用
WO2024109767A1 (zh) 基于粪便代谢物的阿尔兹海默症标志物及其应用
Cheng et al. Factors associated with elevated plasma phenylalanine in patients with heart failure
Tong et al. Identification of salivary peptidomic biomarkers in chronic kidney disease patients undergoing haemodialysis
JP5748751B2 (ja) 糖尿病前症及び２型糖尿病における血清アミロイドの表現型比率
Blonder et al. Proteomic biomarker discovery: it's more than just mass spectrometry
CN110045126B (zh) 一种用于诊断自身免疫性胰腺炎的生物标志物及其用途
WO2024109768A1 (zh) 基于血液代谢物的阿尔茨海默症标志物及其应用
JP6128631B2 (ja) 糖尿病性腎症鑑別用マーカー及びその用途
CN112599237B (zh) 一种生物标志物及其在脑梗死诊断中的应用
CN118275706A (zh) 用于诊断肺癌分型的代谢标志物
CN112305089B (zh) 一种慢性肾病诊断生物标记物及其应用
CN113655141A (zh) 一种早期预警重症急性胰腺炎的血清极性小分子预测模型与应用
CN115469026B (zh) 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途
CN111413447A (zh) 鹅去氧胆酸或/和牛磺酸鹅去氧胆酸在胆管癌诊断方面的应用
CN118091146A (zh) 基于血液代谢物的神经退行性疾病标志物及其应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130318

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130917

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131211

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140117

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140124

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140207

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141113

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150414

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150512

R150 Certificate of patent or registration of utility model

Ref document number: 5748751

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250